Cargando…
Design, Synthesis, and Biological Evaluation of 2-Hydroxy-4-phenylthiophene-3-carbonitrile as PD-L1 Antagonist and Its Comparison to Available Small Molecular PD-L1 Inhibitors
[Image: see text] In search of a potent small molecular PD-L1 inhibitor, we designed and synthesized a compound based on a 2-hydroxy-4-phenylthiophene-3-carbonitrile moiety. Ligand’s performance was tested in vitro and compared side-by-side with a known PD-L1 antagonist with a proven bioactivity BMS...
Autores principales: | Ważyńska, Marta A., Butera, Roberto, Requesens, Marta, Plat, Annechien, Zarganes-Tzitzikas, Tryfon, Neochoritis, Constantinos G., Plewka, Jacek, Skalniak, Lukasz, Kocik-Krol, Justyna, Musielak, Bogdan, Magiera-Mularz, Katarzyna, Rodriguez, Ismael, Blok, Simon N., de Bruyn, Marco, Nijman, Hans W., Elsinga, Philip H., Holak, Tad A., Dömling, Alexander |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10388299/ https://www.ncbi.nlm.nih.gov/pubmed/37450644 http://dx.doi.org/10.1021/acs.jmedchem.3c00254 |
Ejemplares similares
-
Design, Synthesis, and Biological Evaluation of Imidazopyridines
as PD-1/PD-L1 Antagonists
por: Butera, Roberto, et al.
Publicado: (2021) -
PD-L1 Inhibitors: Different Classes, Activities, and Mechanisms of Action
por: Surmiak, Ewa, et al.
Publicado: (2021) -
CA-170 – A Potent Small-Molecule PD-L1 Inhibitor or Not?
por: Musielak, Bogdan, et al.
Publicado: (2019) -
Di-bromo-Based
Small-Molecule Inhibitors of
the PD-1/PD-L1 Immune Checkpoint
por: Konieczny, Magdalena, et al.
Publicado: (2020) -
Human and mouse PD-L1: similar molecular structure, but different druggability profiles
por: Magiera-Mularz, Katarzyna, et al.
Publicado: (2020)